Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.
The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.
Links to related guidelines are provided separately:
●(See "Society guideline links: Sexually transmitted infections".)
●(See "Society guideline links: Opportunistic infections in adults and adolescents with HIV".)
●(See "Society guideline links: Solid organ transplantation in individuals with HIV".)
International
●World Health Organization (WHO): Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy (2017)
●WHO: Consolidated guidelines on HIV prevention, diagnosis, treatment, and care for key populations, update (2016)
●WHO: Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection – Recommendations for a public health approach, second edition (2016)
●WHO: Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV (2015)
Canada
●Choosing Wisely Canada: Don't routinely repeat CD4 measurements in patients with HIV infection with HIV-1 RNA suppression for >2 years and CD4 counts >500/mcL, unless virologic failure occurs or intercurrent opportunistic infection develops (2022)
United States
●Centers for Disease Control and Prevention (CDC): Persons with HIV – Prevention and care: Guidelines
●Department of Health and Human Services (DHHS) Panel on Antiretroviral Guidelines for Adults and Adolescents: Guidelines for the use of antiretroviral agents in adults and adolescents with HIV (2022)
●International Antiviral Society-USA Panel (IAS-USA): Recommendations on antiretroviral drugs for treatment and prevention of HIV infection in adults (2022)
●IAS-USA: Recommendations on drug resistance mutations in HIV-1, update (2022)
●CDC: Sexually transmitted infections treatment guidelines – HIV infection: Detection, counseling, and referral (2021)
●HIV Medicine Association (HIVMA) of the Infectious Diseases Society of America (IDSA): Primary care guidance for persons with human immunodeficiency virus, update (2020)
●Choosing Wisely: Avoid quarterly viral load testing of patients who have durable viral suppression, unless clinically indicated (2016)
●Choosing Wisely: Avoid unnecessary CD4 tests (2016)
●Choosing Wisely: Don't order complex lymphocyte panels when ordering CD4 counts (2016)
Europe
●European AIDS Clinical Society (EACS): Guidelines (2020)
United Kingdom
●British HIV Association (BHIVA): Current guidelines
Australia-New Zealand
●Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM): Antiretroviral guidelines
